Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             29 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activated partial thromboplastin time sensitivity to lupus anticoagulant in a patient with transient arthritis and lupus anticoagulant-hypoprothrombinemia syndrome Mauge, Laetitia
2014
94 4 p. 713-715
artikel
2 Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide Lau, I-Jun
2014
94 4 p. 643-649
artikel
3 Cutaneous Langerhans cell sarcoma relapsing systemically: Complete remission with the EPIG regimen Kwong, Yok-Lam
2014
94 4 p. 697-699
artikel
4 Cutaneous presentation of an aggressive plasmablastic neoplasm indiscriminate between lymphoma and myeloma Johnston, Alice C.
2014
94 4 p. 691-692
artikel
5 Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with l-asparaginase-containing chemotherapy—a single institution experience Zang, Jian
2014
94 4 p. 583-591
artikel
6 Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry Poel, M. W. M. van der
2014
94 4 p. 651-661
artikel
7 Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera Cherry, Mohamad
2014
94 4 p. 717-719
artikel
8 Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities? Sánchez, L. A. Guardado
2014
94 4 p. 609-616
artikel
9 Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation Brissot, Eolia
2014
94 4 p. 663-669
artikel
10 Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts Font, Patricia
2014
94 4 p. 565-573
artikel
11 Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy Kuroda, Junya
2014
94 4 p. 687-689
artikel
12 L-carnitine effectively improves the metabolism and quality of platelet concentrates during storage Deyhim, Mohammad Reza
2014
94 4 p. 671-680
artikel
13 Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma Han, Jae Joon
2014
94 4 p. 575-581
artikel
14 Molecular analysis of loss of CCR4 expression during mogamulizumab monotherapy in an adult T cell leukemia/lymphoma patient Taguchi, Masataka
2014
94 4 p. 693-695
artikel
15 Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation Jeong, Seong Hyun
2014
94 4 p. 617-625
artikel
16 Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial Wasle, Ines
2014
94 4 p. 593-601
artikel
17 Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma Higo, Takashi
2014
94 4 p. 683-685
artikel
18 Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 109/L monoclonal lymphocytes better identifies subgroups with different outcomes Oliveira, A. C.
2014
94 4 p. 627-632
artikel
19 Quality assessment of autologous haematopoietic blood progenitor cell grafting Lanza, Francesco
2014
94 4 p. 705-706
artikel
20 Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin’s lymphoma Czuczman, Myron S.
2015
94 4 p. 633-641
artikel
21 Safety and efficacy of ruxolitinib in a profoundly thrombocytopenic patient with myelofibrosis Armstrong, C.
2014
94 4 p. 711-712
artikel
22 Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphoma Hara, Masaki
2014
94 4 p. 603-608
artikel
23 Severe haemophagocytic lymphohistiocytosis triggered by a visceral leishmaniasis in a patient with a Rosai-Dorfman disease Comont, Thibault
2014
94 4 p. 701-702
artikel
24 The Canadian Choosing Wisely campaign: the Canadian Hematology Society’s top five tests and treatments Hillis, Christopher M.
2015
94 4 p. 541-545
artikel
25 The first two cases of MYH9 disorders in Thailand: an international collaborative study Sirachainan, Nongnuch
2014
94 4 p. 707-709
artikel
26 The immunoglobulin isotype matters in diffuse-large-B-cell lymphoma with serum paraproteinaemia Cox, M. Christina
2014
94 4 p. 681-682
artikel
27 Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients—an evidence-based approach Karthaus, Meinolf
2015
94 4 p. 547-556
artikel
28 Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial Röllig, Christoph
2014
94 4 p. 557-563
artikel
29 Unilateral hearing loss due to lymphocytosis and a contralateral putamen lesion Wong, Hilda
2014
94 4 p. 703-704
artikel
                             29 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland